Webb13 maj 2024 · The Indian pharma industry are faced with challenges like slowing exports and rising costs. This has impacted their ability to capture a larger share of global … WebbThe main objective of this paper is to analyze the Indian biosimilar pharmaceutical market and its growth prospects. The present study discusses the biosimilar market’s current status, growth pattern, various challenges and future perspective in terms of exports.
Domestic aviation industry on recovery path; passenger traffic 60% ...
WebbIndia Brand Equity Foundation (IBEF) is a Trust established by the Department of Commerce, Ministry of Commerce and Industry, Government of India. IBEF's primary objective is to promote and... Webb4 juni 2024 · It is noteworthy that CRAMS and biotechnology-based pharmaceuticals (bio-pharma producing biologics/biosimilars) are an emerging industry in India ( IBEF, 2024 ). The performance of Indian pharmaceuticals is … skrillex glasses hot topic
Fortune India: Business News, Strategy, Finance and Corporate …
Webb23 mars 2024 · IBEF @Brands_India Assistance to the pharma industry has been provided for Common Facilities Scheme with an outlay of US$ 61.1 million (Rs. 500 crores). #BrandIndia Read more: ibef.org/industry/pharm … ALT 9:55 AM · … WebbIBEF has undertaken Sectoral Branding Initiatives and identified its areas of focus to be pharmaceuticals, engineering, services, plantations, leather, textiles, and carpets. The … Webb23 aug. 2024 · The growth is led by a 6-8 per cent average price increase which was allowed by the National Pharmaceutical Pricing Authority in March 2024 and on the back of new product launches. Lifestyle-related chronic portfolio drugs and a few acute portfolio drugs are expected to drive demand this fiscal. skrillex first of year